Evidence map›Paper›PMID 39976700›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Head-to-head evaluation of [

Xiao Zhang, Yongkang Gai, Ting Ye, Li Fan, Linfeng Xiu, Weiwei Ruan, Fan Hu, Jing Chen, Xiaoli Lan

2 registry-linked trialsAbstract readClinical Trial, Phase I
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05490849 early_phase1unknown statusnot on this map

68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

TypeinterventionalSponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRan2021 to 2023Enrolled100ConditionsMalignant NeoplasmArms68Ga-HX01
NCT06416774 phase1completednot on this map

A Phase I Clinical Study to Evaluate the Safety, Biodistribution, Radiation Dose and Pharmacokinetics of 68Ga-HX01 Injection for PET Imaging

TypeinterventionalSponsorHexin (Suzhou) Pharmaceutical Technology Co., LtdRan2022 to 2023Enrolled22ConditionsHealthy, MalignancyArms68Ga-HX01 Injection(0.05mCi/kg), 68Ga-HX01 Injection(0.1mCi/kg), 68Ga-HX01 Injection(0.07mCi/kg)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiao Zhang *Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Hubei, 430022, Wuhan, China.
Yongkang Gai *Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Hubei, 430022, Wuhan, China.
Ting YeCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, Hubei, 430022, China.
Li FanCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, Hubei, 430022, China.
Linfeng XiuHexin (Suzhou) Pharmaceutical Technology Co., Ltd, Taicang, Jiangsu, 215421, China.
Weiwei RuanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Hubei, 430022, Wuhan, China.
Fan HuDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Hubei, 430022, Wuhan, China.
Jing ChenHexin (Suzhou) Pharmaceutical Technology Co., Ltd, Taicang, Jiangsu, 215421, China. chenjingunion@163.com.
Xiaoli LanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Hubei, 430022, Wuhan, China. lxl730724@hotmail.com.ORCID 0000-0002-7263-7399

Funding

Hubei Provincial Natural Science Foundation 2022CFB063Key Research and Development Program of Hubei Province 2023BCB016National Natural Science Foundation of China 82030052National Natural Science Foundation of China 82272843National Natural Science Foundation of China 82373050
6 · The paper itself

Abstract

purposeTumor-associated neovasculature and energy metabolism reprogramming serve as critical indicators of tumor proliferation, progression, invasion, and metastasis. This study conducted a head-to-head clinical investigation and comparison of [

methodsWe reviewed the imaging data of sarcoma patients who underwent [

resultsAmong the 21 patients, 4 underwent imaging for initial disease staging, while the remaining 17 were imaged to detect recurrences. Patient-based analysis revealed that [

conclusion[ CLINICAL

trial registrationNCT05490849 and NCT06416774.

Indexed as

Coordination ComplexesFluorodeoxyglucose F18Magnetic Resonance ImagingPositron Emission Tomography Computed TomographySarcomaAdultAgedFemaleGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedCoordination ComplexesFluorodeoxyglucose F18Gallium IsotopesGallium Radioisotopes[18F]FDG[68Ga]Ga‑HX01Dual-targetPET/MRSarcoma

Identifiers

PMID39976700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.